159 related articles for article (PubMed ID: 30153493)
41. Changes in firing rate and pattern of GABAergic neurons in subregions of the substantia nigra pars reticulata in rat models of Parkinson's disease.
Wang Y; Zhang QJ; Liu J; Ali U; Gui ZH; Hui YP; Chen L; Wang T
Brain Res; 2010 Apr; 1324():54-63. PubMed ID: 20149784
[TBL] [Abstract][Full Text] [Related]
42. Quantitative proteomic profiling of the rat substantia nigra places glial fibrillary acidic protein at the hub of proteins dysregulated during aging: Implications for idiopathic Parkinson's disease.
Gómez-Gálvez Y; Fuller HR; Synowsky S; Shirran SL; Gates MA
J Neurosci Res; 2020 Jul; 98(7):1417-1432. PubMed ID: 32270889
[TBL] [Abstract][Full Text] [Related]
43. Angiotensin-II Modulates GABAergic Neurotransmission in the Mouse Substantia Nigra.
Singh MR; Vigh J; Amberg GC
eNeuro; 2021; 8(2):. PubMed ID: 33771900
[TBL] [Abstract][Full Text] [Related]
44. Role of adenosine A3 receptors on CA1 hippocampal neurotransmission during oxygen-glucose deprivation episodes of different duration.
Pugliese AM; Coppi E; Volpini R; Cristalli G; Corradetti R; Jeong LS; Jacobson KA; Pedata F
Biochem Pharmacol; 2007 Sep; 74(5):768-79. PubMed ID: 17626785
[TBL] [Abstract][Full Text] [Related]
45. MPP(+) injection into rat substantia nigra causes secondary glial activation but not cell death in the ipsilateral striatum.
Canudas AM; Friguls B; Planas AM; Gabriel C; Escubedo E; Camarasa J; Camins A; Pallàs M
Neurobiol Dis; 2000 Aug; 7(4):343-61. PubMed ID: 10964606
[TBL] [Abstract][Full Text] [Related]
46. A partial lesion of the substantia nigra pars compacta and retrorubral field decreases the harmaline-induced glutamate release in the rat cerebellum.
Gołembiowska K; Berghauzen-Maciejewska K; Górska A; Kamińska K; Ossowska K
Brain Res; 2013 Nov; 1537():303-11. PubMed ID: 24012623
[TBL] [Abstract][Full Text] [Related]
47. Excitatory drive from the Subthalamic nucleus attenuates GABAergic transmission in the Substantia Nigra pars compacta via endocannabinoids.
Freestone PS; Wu XH; de Guzman G; Lipski J
Eur J Pharmacol; 2015 Nov; 767():144-51. PubMed ID: 26472124
[TBL] [Abstract][Full Text] [Related]
48. Soluble cpg15 from Astrocytes Ameliorates Neurite Outgrowth Recovery of Hippocampal Neurons after Mouse Cerebral Ischemia.
Zhao JJ; Hu JX; Lu DX; Ji CX; Qi Y; Liu XY; Sun FY; Huang F; Xu P; Chen XH
J Neurosci; 2017 Feb; 37(6):1628-1647. PubMed ID: 28069924
[TBL] [Abstract][Full Text] [Related]
49. GABAergic control of substantia nigra dopaminergic neurons.
Tepper JM; Lee CR
Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
[TBL] [Abstract][Full Text] [Related]
50. Oxygen-glucose deprivation induced glial scar-like change in astrocytes.
Wang R; Zhang X; Zhang J; Fan Y; Shen Y; Hu W; Chen Z
PLoS One; 2012; 7(5):e37574. PubMed ID: 22629422
[TBL] [Abstract][Full Text] [Related]
51. γ-Aminobutyric acid type B receptor changes in the rat striatum and substantia nigra following intrastriatal quinolinic acid lesions.
Rekik L; Daguin-Nerrière V; Petit JY; Brachet P
J Neurosci Res; 2011 Apr; 89(4):524-35. PubMed ID: 21290407
[TBL] [Abstract][Full Text] [Related]
52. Astrocytic Ca(2+) waves mediate activation of extrasynaptic NMDA receptors in hippocampal neurons to aggravate brain damage during ischemia.
Dong QP; He JQ; Chai Z
Neurobiol Dis; 2013 Oct; 58():68-75. PubMed ID: 23702310
[TBL] [Abstract][Full Text] [Related]
53. Glutamate transporter 1-expressing glia in the rat substantia nigra-Morphometric analysis and relationships to synapses.
Kessler JP; Salin P; Kerkerian-Le Goff L
Glia; 2020 Oct; 68(10):2028-2039. PubMed ID: 32170887
[TBL] [Abstract][Full Text] [Related]
54. Ginkgolide K promotes astrocyte proliferation and migration after oxygen-glucose deprivation via inducing protective autophagy through the AMPK/mTOR/ULK1 signaling pathway.
Zhang Y; Miao JM
Eur J Pharmacol; 2018 Aug; 832():96-103. PubMed ID: 29787772
[TBL] [Abstract][Full Text] [Related]
55. Mechanisms underlying the rapid depolarization produced by deprivation of oxygen and glucose in rat hippocampal CA1 neurons in vitro.
Tanaka E; Yamamoto S; Kudo Y; Mihara S; Higashi H
J Neurophysiol; 1997 Aug; 78(2):891-902. PubMed ID: 9307122
[TBL] [Abstract][Full Text] [Related]
56. Intrapallidal lipopolysaccharide injection increases iron and ferritin levels in glia of the rat substantia nigra and induces locomotor deficits.
Zhang J; Stanton DM; Nguyen XV; Liu M; Zhang Z; Gash D; Bing G
Neuroscience; 2005; 135(3):829-38. PubMed ID: 16165292
[TBL] [Abstract][Full Text] [Related]
57. Dopamine cell morphology and glial cell hypertrophy and process branching in the nigrostriatal system after striatal 6-OHDA analyzed by specific sterological tools.
Gomide V; Bibancos T; Chadi G
Int J Neurosci; 2005 Apr; 115(4):557-82. PubMed ID: 15804725
[TBL] [Abstract][Full Text] [Related]
58. Electrophysiological Characterization of Novel Effects of the Uptake-2 Blocker Decynium-22 (D-22) on Dopaminergic Neurons in the Substantia Nigra Pars Compacta.
Lloyd JT; Martini A; McDouall A; Sood R; Freestone PS; Mercuri NB; Lipski J
Neuroscience; 2019 Jan; 396():154-165. PubMed ID: 30447392
[TBL] [Abstract][Full Text] [Related]
59. The Selective Antagonism of Adenosine A
Fusco I; Ugolini F; Lana D; Coppi E; Dettori I; Gaviano L; Nosi D; Cherchi F; Pedata F; Giovannini MG; Pugliese AM
Front Pharmacol; 2018; 9():399. PubMed ID: 29740323
[TBL] [Abstract][Full Text] [Related]
60. Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.
Proença MB; Dombrowski PA; Da Cunha C; Fischer L; Ferraz AC; Lima MM
Neuropharmacology; 2014 Jan; 76 Pt A():118-26. PubMed ID: 24012539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
